ROME, March 11 (Reuters) - Italy's medicines authority Aifa
said on Thursday it would ban the use of doses of the
AstraZeneca vaccine belonging to the ABV2856 batch after
notifications of some serious adverse effects.
Aifa said that the move was "precautionary" as no link
between the inoculation of the vaccine and these events had been
established to date.
The agency is carrying out all required checks and the batch
will be analysed by Italy's Superior Health Institute ISS, it
added.
(Reporting by Emilio Parodi, writing by Giulia Segreti; editing
by Agnieszka Flak)
Astrazeneca (AZN)
